GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Short Percentage of Float

Elanix Biotechnologies AG (FRA:ELN) Short Percentage of Float


View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Elanix Biotechnologies AG's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Short Percentage of Float falls into.


Elanix Biotechnologies AG (FRA:ELN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Short Percentage of Float
Comparable Companies
XSAT:ACUC XCNQ:VENI BOM:524202 CXUS ETST INNV BOM:524711 BOM:531726 CYIG ASX:AZT BOM:530233 SGX:BFK BUE:ROSE WAR:CBD XCNQ:RQB NSE:PAR BOM:540694 TSXV:GYSR OSTO:GABA XCNQ:GSTR
Traded in Other Exchanges
N/A
Address
Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474
Website
https://www.elanixbiotechnologies.ch
Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines